» Articles » PMID: 30890073

Excitatory Pathway Engaging Glutamate, Calcineurin, and NFAT Upregulates IL-4 in Ischemic Neurons to Polarize Microglia

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Excitotoxicity and microglia/macrophage over-activation are the important pathogenic steps in brain damage caused by ischemic stroke. Recent studies from our group suggest that the neurons in ischemic penumbra generate an anti-inflammatory cytokine, interleukin-4 (IL-4). This neuron-produced IL-4 could subsequently convert surrounding microglia/macrophages to a reparative (M2)-phenotype. The present study was designed to establish the mechanisms by which neurons under transient ischemic condition produce/secrete IL-4. We employed primary rat cortical neurons and a validated in vitro ischemic injury model involving transient oxygen-glucose deprivation (OGD). We discovered that only sublethal OGD induces IL-4 production/secretion by neurons. We then showed that excitotoxic stimulus (an integral component of OGD-mediated damage) involving N-methyl-D-aspartate (NMDA), and not kainate receptor, triggers neuronal IL-4 production/release. Of note, oxidative stress or pro-apoptotic stimuli did not induce IL-4 production by neurons. Next, using the calcineurin inhibitor FK506, we implicated this phosphatase in activation of the nuclear factor of activated T-cells (NFAT; a transcription factor activated through calcineurin-mediated dephosphorylation) and propose that this pathway is involved in transcriptional upregulation of the IL-4 synthesis in NMDA-treated neurons. Finally, using a transfer of culture medium from NMDA-conditioned neuron to microglia, we showed that the neuronal IL-4 can polarize microglia toward a restorative, phagocytic phenotype.

Citing Articles

Calcineurin inhibition may prevent Alzheimer disease in people with Down syndrome.

Dohl J, Treadwell Z, Norris C, Head E Alzheimers Dement. 2025; 21(3):e70034.

PMID: 40042516 PMC: 11881635. DOI: 10.1002/alz.70034.


Delta-opioid receptor signaling alleviates neuropathology and cognitive impairment in the mouse model of Alzheimer's disease by regulating microglia homeostasis and inhibiting HMGB1 pathway.

Xu Y, Shao N, Zhi F, Chen R, Yang Y, Li J Alzheimers Res Ther. 2025; 17(1):35.

PMID: 39893485 PMC: 11786345. DOI: 10.1186/s13195-025-01682-1.


Early-life IL-4 administration induces long-term changes in microglia in the cerebellum and prefrontal cortex.

Ferreira P, Lebre C, Costa J, Amaral F, Ferreira R, Martinho F J Neurochem. 2024; 169(1):e16266.

PMID: 39676699 PMC: 11647562. DOI: 10.1111/jnc.16266.


Cerebrospinal fluid metabolomes of treatment-resistant depression subtypes and ketamine response: a pilot study.

Berner J, Acharjee A Discov Ment Health. 2024; 4(1):12.

PMID: 38630417 PMC: 11024073. DOI: 10.1007/s44192-024-00066-5.


Targeting CaN/NFAT in Alzheimer's brain degeneration.

Mackiewicz J, Lisek M, Boczek T Front Immunol. 2023; 14:1281882.

PMID: 38077352 PMC: 10701682. DOI: 10.3389/fimmu.2023.1281882.


References
1.
Hogan P, Chen L, Nardone J, Rao A . Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 2003; 17(18):2205-32. DOI: 10.1101/gad.1102703. View

2.
Ren Y, Silverstein R, Allen J, Savill J . CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J Exp Med. 1995; 181(5):1857-62. PMC: 2192004. DOI: 10.1084/jem.181.5.1857. View

3.
Zhao X, Sun G, Zhang J, Strong R, Song W, Gonzales N . Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages. Ann Neurol. 2007; 61(4):352-62. DOI: 10.1002/ana.21097. View

4.
Nakazawa K, McHugh T, Wilson M, Tonegawa S . NMDA receptors, place cells and hippocampal spatial memory. Nat Rev Neurosci. 2004; 5(5):361-72. DOI: 10.1038/nrn1385. View

5.
Vihma H, Luhakooder M, Pruunsild P, Timmusk T . Regulation of different human NFAT isoforms by neuronal activity. J Neurochem. 2016; 137(3):394-408. DOI: 10.1111/jnc.13568. View